Browse > Article
http://dx.doi.org/10.5483/BMBRep.2015.48.11.130

Epigenetic silencing of olfactomedin-4 enhances gastric cancer cell invasion via activation of focal adhesion kinase signaling  

Guo, Li-Li (Department of Gastroenterology, Heping Hospital, Changzhi Medical College)
He, Zhao-Cai (Department of General Surgery, Heping Hospital, Changzhi Medical College)
Yang, Chang-Qing (Department of Gastroenterology, Heping Hospital, Changzhi Medical College)
Qiao, Pei-Tang (Department of Gastroenterology, Heping Hospital, Changzhi Medical College)
Yin, Guo-Ling (Department of radiotherapy, Heping Hospital, Changzhi Medical College)
Publication Information
BMB Reports / v.48, no.11, 2015 , pp. 630-635 More about this Journal
Abstract
Downregulation of olfactomedin-4 (OLFM4) is associated with tumor progression, lymph node invasion and metastases. However, whether or not downregulation of OLFM4 is associated with epigenetic silencing remains unknown. In this study, we investigate the role of OLFM4 in gastric cancer cell invasion. We confirm the previous result that OLFM4 expression is increased in gastric cancer tissues and decreases with an increasing number of metastatic lymph nodes, which are associated with OLFM4 promoter hypermethylation. Overexpression of OLFM4 in gastric cancer cells had an inhibitory effect on cell invasion. Furthermore, we found that focal adhesion kinase (FAK) was negatively correlated with OLFM4 in regards to lymph node metastasis in gastric cancer tissues. Also, inhibition of FAK induced by OLFM4 knockdown resulted in a decrease in cell invasion. Thus, our study demonstrates that epigenetic silencing of OLFM4 enhances gastric cancer cell invasion via activation of FAK signaling.
Keywords
Focal adhesion kinase; Gastric cancer; Invasion; Matrix metalloproteinases; Metastasis; Olfactomedin-4;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Clemmensen SN, Bohr CT, Rorvig S et al (2012) Olfactomedin 4 defines a subset of human neutrophils. J Leukoc Biol 91, 495-500   DOI
2 Chin KL, Aerbajinai W, Zhu J et al (2008) The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor. Br J Haematol 143, 421-432   DOI
3 Sun F, Peatman E, Li C et al (2012) Transcriptomic signatures of attachment, NF-kappaB suppression and IFN stimulation in the catfish gill following columnaris bacterial infection. Dev Comp Immunol 38, 169-180   DOI
4 Grover PK, Hardingham JE, Cummins AG (2010) Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis. Cancer Metastasis Rev 29, 761-775   DOI
5 Besson D, Pavageau AH, Valo I et al (2011) A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker. Mol Cell Proteomics 10, M111-M9712   DOI
6 Luo Z, Zhang Q, Zhao Z, Li B, Chen J, Wang Y (2011) OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer. J Cancer Res Clin Oncol 137, 1713-1720   DOI
7 Yu L, Wang L, Chen S (2011) Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers. Neoplasma 58, 9-13   DOI
8 Sampieri CL, Leon-Cordoba K, Remes-Troche JM (2013) Matrix metalloproteinases and their tissue inhibitors in gastric cancer as molecular markers. J Cancer Res Ther 9, 356-363   DOI
9 Jang BG, Lee BL, Kim WH (2015) Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer. Virchows Arch 467, 285-294   DOI
10 Yamanoi K, Arai E, Tian Y et al (2015) Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome. Carcinogenesis 36, 509-520   DOI
11 Carneiro P, Figueiredo J, Bordeira-Carrico R et al (2013) Therapeutic targets associated to E-cadherin dysfunction in gastric cancer. Expert Opin Ther Targets 17, 1187-1201   DOI
12 Koshida S, Kobayashi D, Moriai R, Tsuji N, Watanabe N (2007) Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis. Cancer Sci 98, 315-320   DOI
13 Liu W, Zhu J, Cao L, Rodgers GP (2007) Expression of hGC-1 is correlated with differentiation of gastric carcinoma. Histopathology 51, 157-165   DOI
14 Oue N, Sentani K, Noguchi T et al (2009) Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer 125, 2383-2392   DOI
15 Suh YS, Lee HJ, Jung EJ et al (2012) The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer. Ann Surg Oncol 19, 1240-1249   DOI
16 He D, Zhang YW, Zhang NN et al (2015) Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas. Med Oncol 32, 92   DOI
17 Zouridis H, Deng N, Ivanova T et al (2012) Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci Transl Med 4, 140r-156r   DOI
18 Dauksa A, Gulbinas A, Endzinas Z, Oldenburg J, El-Maarri O (2014) DNA methylation at selected CpG sites in peripheral blood leukocytes is predictive of gastric cancer. Anticancer Res 34, 5381-5388
19 Du T, Qu Y, Li J et al (2014) Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway. Mol Cancer 13, 100   DOI
20 Zhao C, Bu X (2012) Promoter methylation of tumor-related genes in gastric carcinogenesis. Histol Histopathol 27, 1271-1282
21 Roberts WG, Ung E, Whalen P et al (2008) Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Cancer Res 68, 1935-1944   DOI
22 Mon NN, Ito S, Senga T, Hamaguchi M (2006) FAK signaling in neoplastic disorders: a linkage between inflammation and cancer. Ann N Y Acad Sci 1086, 199-212   DOI
23 Zhang J, Liu WL, Tang DC et al (2002) Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development. Gene 283, 83-93   DOI
24 Park KS, Kim KK, Piao ZH et al (2012) Olfactomedin 4 suppresses tumor growth and metastasis of mouse melanoma cells through downregulation of integrin and MMP genes. Mol Cells 34, 555-561   DOI
25 Liu RH, Yang MH, Xiang H et al (2012) Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cells. J Biomed Sci 19, 38   DOI